Literature DB >> 33907929

Is heart failure with preserved ejection fraction a 'dementia' of the heart?

Giacomo Tini1,2, Antonio Cannatà3, Marco Canepa4, Pier Giorgio Masci5, Matteo Pardini6,7, Mauro Giacca8, Gianfranco Sinagra3, Niccolò Marchionni9, Federica Del Monte10, James E Udelson11, Iacopo Olivotto12,9.   

Abstract

Heart failure with preserved ejection fraction (HFpEF) remains an elusive entity, due to its heterogeneous clinical profile and an arbitrarily defined nosology. Several pathophysiological mechanisms recognized as central for the development of HFpEF appear to be in common with the process of physiological aging of the heart. Both conditions are characterized by progressive impairment in cardiac function, accompanied by left ventricular hypertrophy, diastolic dysfunction, sarcomeric, and metabolic abnormalities. The neurological paradigm of dementia-intended as a progressive, multifactorial organ damage with decline of functional reserve, eventually leading to irreversible dysfunction-is well suited to represent HFpEF. In such perspective, certain phenotypes of HFpEF may be viewed as a maladaptive response to environmental modifiers, causing premature and pathological aging of the heart. We here propose that the 'HFpEF syndrome' may reflect the interplay of adverse structural remodelling and erosion of functional reserve, mirroring the processes leading to dementia in the brain. The resulting conceptual framework may help advance our understanding of HFpEF and unravel potential therapeutical targets.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Calcium handling; Cardiac aging; Dementia; HFpEF; Left ventricular hypertrophy; Myocardial fibrosis

Mesh:

Year:  2021        PMID: 33907929     DOI: 10.1007/s10741-021-10114-9

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


  48 in total

1.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Mark H Drazner; Gregg C Fonarow; Stephen A Geraci; Tamara Horwich; James L Januzzi; Maryl R Johnson; Edward K Kasper; Wayne C Levy; Frederick A Masoudi; Patrick E McBride; John J V McMurray; Judith E Mitchell; Pamela N Peterson; Barbara Riegel; Flora Sam; Lynne W Stevenson; W H Wilson Tang; Emily J Tsai; Bruce L Wilkoff
Journal:  J Am Coll Cardiol       Date:  2013-06-05       Impact factor: 24.094

2.  Phenomapping for novel classification of heart failure with preserved ejection fraction.

Authors:  Sanjiv J Shah; Daniel H Katz; Senthil Selvaraj; Michael A Burke; Clyde W Yancy; Mihai Gheorghiade; Robert O Bonow; Chiang-Ching Huang; Rahul C Deo
Journal:  Circulation       Date:  2014-11-14       Impact factor: 29.690

3.  Letter regarding the article 'Heart failure with preserved ejection fraction: from mechanisms to therapies' by Lam and colleagues.

Authors:  Giacomo Tini; Iacopo Olivotto; Marco Canepa
Journal:  Eur Heart J       Date:  2019-02-21       Impact factor: 29.983

Review 4.  Heart failure with preserved ejection fraction: molecular pathways of the aging myocardium.

Authors:  Francesco S Loffredo; Andriana P Nikolova; James R Pancoast; Richard T Lee
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 5.  Heart Failure With Preserved Ejection Fraction: A Kidney Disorder?

Authors:  James C Fang
Journal:  Circulation       Date:  2016-08-09       Impact factor: 29.690

Review 6.  Systematic review of recent dementia practice guidelines.

Authors:  Jennifer Ngo; Jayna M Holroyd-Leduc
Journal:  Age Ageing       Date:  2014-10-22       Impact factor: 10.668

Review 7.  A clinicopathological approach to the diagnosis of dementia.

Authors:  Fanny M Elahi; Bruce L Miller
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

Review 8.  Heart failure with preserved ejection fraction: from mechanisms to therapies.

Authors:  Carolyn S P Lam; Adriaan A Voors; Rudolf A de Boer; Scott D Solomon; Dirk J van Veldhuisen
Journal:  Eur Heart J       Date:  2018-08-07       Impact factor: 29.983

9.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

Review 10.  Biological Phenotypes of Heart Failure With Preserved Ejection Fraction.

Authors:  Gavin A Lewis; Erik B Schelbert; Simon G Williams; Colin Cunnington; Fozia Ahmed; Theresa A McDonagh; Christopher A Miller
Journal:  J Am Coll Cardiol       Date:  2017-10-24       Impact factor: 24.094

View more
  2 in total

Review 1.  Drug Treatment of Heart Failure in Children: Gaps and Opportunities.

Authors:  Molly Weisert; Jennifer A Su; Jondavid Menteer; Robert E Shaddy; Paul F Kantor
Journal:  Paediatr Drugs       Date:  2022-01-27       Impact factor: 3.022

Review 2.  Heart Failure with Preserved Ejection Fraction in Children.

Authors:  Bibhuti Das; Shriprasad Deshpande; Jyothsna Akam-Venkata; Divya Shakti; William Moskowitz; Steven E Lipshultz
Journal:  Pediatr Cardiol       Date:  2022-08-17       Impact factor: 1.838

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.